Discover Great Companies Discover Great Clients
Popularity  5.5万   |   Followers  22   |   Likes  15   |   Feedback  18 Claim this company

Industrialization platform of the National Engineering Research Center

No.166 Yizhuang Development Zone Popularity Ranking Beijing No.2 Shi Pin Wei Sheng No.2 Chuan Tong Yi Xue No.2 Yi Chuan Bing Diagnostics No.2 Products Management Detection No.2 Ce Xu Technology No.3 Livestock Technology No.5 Yi Chuan Xue No.5 Genes Technology No.7 Chronic Diseases Management No.8 Diagnostic Reagents No.10 Instrument Equipment No.10 Hao Materials 瞪羚企业 独角兽企业 企业技术中心 专利示范企业 中关村高新技术企业 高新技术企业
More

Company Overview

  • Nature: State-owned Enterprise Size: 1000-4999 employees Founded: 14年
  • Industry: Pharmaceuticals/Biotechnology 、 Medical Devices/Equipment
  • Full name: Beijing CapitalBio Technology Co., Ltd.。

Development Stage

  • Ranking: Ranked #2 in Beijing Shi Pin Wei Sheng Company by popularity Ranked #2 in Beijing Chuan Tong Yi Xue Company by popularity Ranked #2 in Beijing Yi Chuan Bing Diagnostics Company by popularity Ranked #2 in Beijing Products Management Detection Company by popularity
  • Honors: 瞪羚企业 独角兽企业 According to algorithm
  • News: 2020-09-22:独家融资|医疗企业“博奥晶典”获中石化资本等投资 服务已出口30余国。
  • Salary: 63.2% of positions earn 10-30K, In 2026 vs last yeargrew by 13%.。Master's salary: ¥17.9K, Doctorate salary: ¥27.8K.
  • R&D: "Scientific Research" demand: 22.8%, "Biology/Pharmaceutical/Chemical/Environmental Protection": 18.8%, "Medical & Health/Beauty & Healthcare": 17%。
  • Recruiting: In 2026 vs 2025decreased by 32%. Demand for highly educated talent: Master's: 27, Doctorate: 3.
  • Requirement: Education: 大专 leads with 47.5%. Experience: 3-5年 leads with 33.4%.
  • Region: Distributed across 18 regions, 北京: 31.1%, 广州: 8.5%, 上海: 5.3%, 成都: 5%.

About the Company

[Summary] Industrialization platform of the National Engineering Research Center

Beijing CapitalBio Technology Co., Ltd. (hereinafter referred to as "CapitalBio Technology") is the industrialization platform of CapitalBio Corporation and the National Engineering Research Center for Beijing Biochip Technology, and is a core enterprise of Tsinghua University in the field of life and health. CapitalBio Technology was registered and established in August 2012, with production, R&D bases, marketing and operation centers for biochips and instruments in Beijing, Shanghai, Chongqing, Chengdu, Dongguan, Hong Kong, and San Diego, USA. It is a typical high-tech enterprise with a mix of intellectual, technological, and capital intensity.
CapitalBio Technology adheres to independent innovation and translation of research achievements, based on the new generation of biological detection technology. It possesses a complete industrial chain integrating R&D, production, sales, and national third-party independent medical laboratory services. In response to the national health policy of "prevention first", it closely combines modern medicine with traditional Chinese medicine, creating a comprehensive health industry sector that integrates health products, health management, medical rehabilitation, and big data. Currently, CapitalBio Technology has subsidiaries including Beijing CapitalBio Medical Laboratory Co., Ltd., Dongguan CapitalBio Muhua Gene Technology Co., Ltd., Chongqing CapitalBio Xinqing Medical Technology Co., Ltd., and CapitalBio Yihe Health Science and Technology (Beijing) Co., Ltd. The diversified group operation structure highlights the advantages and influence of CapitalBio Technology in the three-dimensional development of the life science industry.
Relying on the strong R&D strength of Tsinghua University and the National Engineering Research Center for Beijing Biochip Technology, CapitalBio Technology has obtained over 300 authorized patents at home and abroad, with a patent conversion rate of nearly 50%. It has successfully developed dozens of products and services with independent intellectual property rights, including biochips and related reagents and consumables, instruments and equipment, software databases, life science services, clinical testing services, and health management, among which more than ten are internationally pioneering. Products have obtained over 130 various domestic and international certifications such as CFDA, CE, GS, CB. The company has successively passed the laboratory accreditation of the China National Accreditation Service for Conformity Assessment (CNAS), the certification of TÜV Rheinland quality management system, the accreditation of the American Society for Histocompatibility and Genetics (ASHI), and the accreditation of the College of American Pathologists (CAP).
As one of the earliest approved pilot units for individualized medical testing by the National Health and Family Planning Commission, the CapitalBio Medical Laboratory under CapitalBio Technology has also become one of the first batch of pilot units for clinical application of high-throughput gene sequencing technology in genetic disease diagnosis, prenatal screening and diagnosis, preimplantation embryo genetic diagnosis, and tumor diagnosis and treatment projects. It is also the unit with the most complete qualifications so far. Currently, 23 independent medical testing sub-centers have been approved by the National Development and Reform Commission as national demonstration centers for gene testing technology application.
In recent years, CapitalBio Technology has closely focused on the Healthy China strategy, with a focus on birth defects and chronic disease health management. It has built a birth defect prevention and control system based on 23 national demonstration centers for gene testing technology application, and a chronic disease management system with community chronic disease health management centers as platforms. It adheres to focusing on the grassroots, prevention first, equal emphasis on traditional Chinese and Western medicine, assists local governments in completing medium and long-term chronic disease planning and the Healthy China 2030 chronic disease planning goals, builds innovative national chronic disease prevention and control demonstration zones, promotes the development of the health industry, enhances people's sense of gain and happiness, and reduces the direct and indirect economic burden caused by chronic diseases.
Relying on a sound biotechnology platform, CapitalBio Technology provides instruments, equipment, supporting reagents and consumables, scientific research service outsourcing, and overall experimental solutions to domestic and international life science research, medical testing, new drug development, health management, judicial identification, agriculture, forestry, animal husbandry, and food safety fields. It has established strategic cooperation with nearly 100 well-known domestic top-tier hospitals, universities, public security, and judicial institutions. It has also established partnerships with internationally renowned companies in the life science and medical diagnostics field such as Thermo Fisher Scientific and Roche. Its series of products and services have been exported to more than 30 countries and regions in North America, Europe, Asia, as well as countries along the "Belt and Road" initiative.
In the future, CapitalBio Technology will build a full life cycle, all-round health service system, create a new model of medical and health services suitable for China's national conditions, benefit the people with diversified health products, and contribute to the construction of "Healthy China".

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

CapitalBio Technology How Fast Is Hiring Growing? (86 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Up 36%
  • 2024: Up 49%
  • 2023: Down 11%
  • 2022: Down 44%
CapitalBio Technology Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
CapitalBio Technology Campus Recruitment & Advanced Degree Talent Demand
Master's 27 Doctorate 3
Note: How fast is hiring at Beijing CapitalBio Technology Co., Ltd. growing? CapitalBio Technology2026: 247 openings (down 32%), 2025: 362 openings (up 36%), 2024: 266 openings (up 49%), 2023: 179 openings (down 11%), 2022: 200 openings (down 44%), 2021: 357 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

CapitalBio Technology Master's Degree Job Demand Analysis

(More)
How fast is master's hiring at Beijing CapitalBio Technology Co., Ltd. growing? . CapitalBio Technology master talent ranking in Beijing: #240, CapitalBio Technology master salary mostly around 10-30K.

CapitalBio Technology Doctoral Degree Job Demand Analysis

(More)
How fast is doctoral hiring at Beijing CapitalBio Technology Co., Ltd. growing? . CapitalBio Technology doctorate talent ranking in Beijing: #209, CapitalBio Technology doctorate salary mostly around 20-50K.

CapitalBio Technology R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Beijing CapitalBio Technology Co., Ltd.? Based on an analysis of CapitalBio Technology's job postings over the past year, "Scientific Research" demand: 22.8%, "Biology/Pharmaceutical/Chemical/Environmental Protection": 18.8%, "Medical & Health/Beauty & Healthcare": 17%, "Other (R&D and Technical)": 10.9%, "Computer/Network/Technology": 6.4%, "Agriculture, Forestry and Fishery": 3%. For reference only.

CapitalBio Technology — What Are the Salaries Like? (329 records)

Manage
salary range: 4.5K - 50K, 63.2% of roles pay ¥10-30K
Note: salary statistics are based on 329 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Beijing CapitalBio Technology Co., Ltd.?CapitalBio Technology63.2% of positions earn 10-30K, Fresh graduate salary: ¥2.5K。销售类 average salary ¥15.1K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of CapitalBio Technology

(More)
Are salaries high at Beijing CapitalBio Technology Co., Ltd.? We provide: Sales, Technical Support, Medical Devices, 实验员, Information, Key Account, 省区经理, 总经理, Product Manager, 推广, Account Manager, 打包, 检验, Intern, 科学家, Warehouse Staff, 区域经理, Mechanic, Automation Engineer, 医师. Click to view detailed salary analysis by job.

CapitalBio Technology honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Job Category

  • 销售类
    59.8% of total 59.8%
  • 科研类
    23.8% of total 23.8%
  • 生物/制药/化工/环保类
    20.5% of total 20.5%
  • 医疗卫生/美容保健类
    16.4% of total 16.4%

Education

  • 大专
    47.5% of total 47.5%
  • 本科
    24.3% of total 24.3%
  • 硕士
    21.1% of total 21.1%
  • 博士
    4.7% of total 4.7%

Experience

  • 3-5年
    33.4% of total 33.4%
  • 1-3年
    29% of total 29%
  • 不限
    20.8% of total 20.8%
  • 5-10年
    16.4% of total 16.4%
View Detailed Analysis

What does Beijing CapitalBio Technology Co., Ltd. require? Who is CapitalBio Technology hiring? CapitalBio Technology recruitment: 销售类占比最多占59.8%,其次是科研类占23.8%. What education can get in at CapitalBio Technology? 大专占比最多占47.5%,其次是本科占24.3%. High education required at CapitalBio Technology? 硕士占21.1%,博士占4.7%. Work experience required at CapitalBio Technology? 3-5年占比最多占33.4%,其次是1-3年占29%. Where are the job locations at CapitalBio Technology? 北京占比最多占31.1%,其次是广州占8.5%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 4,557.9757万(元)
Legal Representative: 孙义民
Date Established:
Credit Code: 9111030205136463XD
Registered Address: 北京市北京经济技术开发区科创六街88号院10号楼101室

Partners & Suppliers

签署战略合作协议,共同开发呼吸道病原体核酸检测产品 Source
合作客户 战略合作/联合开发
经销硕世分子诊断产品 Source
供应商 经销商/分销商
塞力斯与博奥生物集团合作,采购博奥晶典分子诊断平台及芯片试剂 Source
合作客户 分子诊断产品供应商
提供基因芯片检测服务 Source
供应商 基因测序服务
博奥晶典在单细胞基因芯片检测中与厦泰开展技术合作。 Source
供应商 科研试剂

People who follow CapitalBio Technology also follow

CapitalBio Technology Competitors (Similar Companies)

“高端引擎和锂电园林工具制造与供应商”
医疗服务 眼科 医院 医疗护理
“To produce more affordable and effective medicines for the Chinese peo”
“Use creativity and technology to drive business and social progress”
“One of the largest and most influential enterprises in China's financi”
涂料 化工/化学 保温涂料 真石漆
保险 寿险 健康保险 保险服务
“Home furnishing brand operator”
“Products for the diagnosis and treatment of allergic diseases”
制冷 压缩机 精密铸造 空调压缩机
钢结构工程 复合板 建筑施工 工程施工
“Top 10 of China Light Industry Plastic Industry”
“Mainly engaged in commodity futures brokerage, financial futures broke”
“Let every Chinese family enjoy the care of professional home medical c”
“研发、生产、销售各种功能性糖醇的国家高新技术企业”

Discover Great Companies, Discover Great Clients

北京公司名录 北京“Yizhuang Development Zone”公司名录 北京“大健康”公司名录 北京“生物科技/生物工程”公司名录 北京“诊断试剂”公司名录 北京“药物研发”公司名录 北京“新药研发”公司名录 附近的公司

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates